The maternal RSV vaccine (Abrysvo) is given once, between 32 weeks 0 days and 36 weeks 6 days of pregnancy, and only during the RSV vaccination season. In most of the continental US, ACOG's 2026–27 guidance sets that season as September 1 through March 1; CDC's guidance page still says September through January. Your dates qualify only where the two windows overlap.
Enter your due date and where you live. The planner draws your 32–36 week window, intersects it with the season, and shows an empty result when there is no overlap. It does not decide whether you should be vaccinated.
Maternal RSV vaccine window
Gestational timing and seasonal timing
Which weeks? The vaccine is approved for use in pregnancy only at 32 0/7 through 36 6/7 weeks. Giving it in late pregnancy lets antibodies cross the placenta in time to protect the baby for roughly the first six months; ACOG also limits it to people without a planned delivery within two weeks, because protection is expected once at least 14 days pass between the dose and the birth.
Does season matter? Yes. Unlike Tdap, which is given in every pregnancy at any time of year, the maternal RSV vaccine is seasonal: it is meant for babies who will be young infants during RSV season. A pregnancy that reaches 32–36 weeks in summer usually relies on an antibody given to the baby instead.
Your two overlapping windows
Does my due date fall in the maternal RSV vaccination season? The question is really whether your 32–36 week dates do. The planner shows both layers on one calendar and lists the shared dates under each season definition, because the two US sources currently differ:
- ACOG 2026–27: September 1 through March 1. ACOG extended the end date in September 2026 after recent seasons peaked later in the spring.
- CDC guidance page: September through January.
Worked example: due date February 1, 2027
32w 0d = February 1, 2027 − 56 days = Monday, December 7, 2026. 36w 6d = February 1, 2027 − 22 days = Sunday, January 10, 2027. All 35 days fall inside the season under both definitions.
Where the definitions differ: due date March 15, 2027
The window runs January 18 to February 21, 2027. Under CDC's September–January wording only January 18–31 (14 days) overlap; under ACOG's September 1–March 1 season the whole 35-day window does. Ask your clinician which guidance your practice follows.
When there is no overlap
For a due date of June 1, 2027, the 32–36 week window is April 6 to May 10, 2027—after March 1, so the planner reports no shared dates. That is an expected result, not an error. ACOG and CDC state that when the maternal vaccine is not given, the infant should receive an RSV monoclonal antibody (nirsevimab or clesrovimab) for the first RSV season, typically at birth or in the first week if born during the season, or before the season begins if born earlier.
A window that only partly overlaps, as in the March 15 example above, still contains eligible dates; the planner lists them exactly.
Regional differences
Why does location affect the timing window? RSV circulates on different calendars in different climates. CDC names Alaska and tropical areas—including southern Florida, Guam, Hawaii, Puerto Rico, the U.S.-affiliated Pacific Islands and the U.S. Virgin Islands—as places where clinicians follow state, local or territorial guidance instead of the national season. If you choose one of those locations, or a country outside the United States, the planner shows only your 32–36 week window and applies no season. Vaccine products and programs differ by country, so check with your local maternity service.
Maternal vaccination and infant prevention discussion
What about previous vaccination? CDC and ACOG currently do not recommend another maternal dose for someone vaccinated in a previous pregnancy; instead, that baby should receive a monoclonal antibody. ACOG notes there are no data yet on additional doses in later pregnancies. Tick the box in the planner if this applies and it will say so above your dates.
Questions to bring to a prenatal visit:
- Does my practice follow the September 1–March 1 season or the September–January season?
- Would you suggest the maternal vaccine or an antibody for the baby, given my dates and my birth plan?
- If the baby is born less than 14 days after my dose, will the baby be offered an antibody?
- How will my vaccination be recorded so the baby's care team can see it?
Other late-pregnancy dates use the same arithmetic: the Tdap timing calculator covers weeks 27 to 36, and the GBS screening date calculator covers the 36-to-37-week swab.
Sources and method notes
- Maternal Respiratory Syncytial Virus Vaccination (Practice Advisory) — American College of Obstetricians and Gynecologists (ACOG), updated September 2, 2026. United States. Source for the September 1 through March 1 season, 32 0/7 to 36 6/7 weeks, no planned delivery within 2 weeks, one dose only, and infant monoclonal antibodies.
- RSV Vaccine Guidance for Pregnant People — Centers for Disease Control and Prevention (CDC), last reviewed August 30, 2024. United States. Source for Abrysvo as the only vaccine for pregnancy, September through January in most of the continental U.S., and jurisdictions with different seasonality.
- Guidelines for Vaccinating Pregnant Women — CDC, last updated August 22, 2025. Maternal vaccination or infant antibody, and no repeat maternal dose in later pregnancies.
- The RSV Vaccine and Pregnancy (patient FAQ) — ACOG. Patient explanation of the 14-day interval before birth.